Chronic methamphetamine abuse and corticostriatal deficits revealed by neuroimaging
Open accessThe DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
Despite aggressive efforts to contain it, methamphetamine use disorder continues to be major public health problem; and with generic behavioral therapies still the mainstay of treatment for methamphetamine abuse, rates of attrition and relapse remain high. This review summarizes the findings of structural, molecular, and functional neuroimaging studies of methamphetamine abusers, focusing on cortical and striatal abnormalities and their potential contributions to cognitive and behavioral phenotypes that can serve to promote compulsive drug use. These studies indicate that individuals with a history of chronic methamphetamine abuse often display several signs of corticostriatal dysfunction, including abnormal gray- and white-matter integrity, monoamine neurotransmitter system deficiencies, neuroinflammation, poor neuronal integrity, and aberrant patterns of brain connectivity and function, both when engaged in cognitive tasks and at rest. More importantly, many of these neural abnormalities were found to be linked with certain addiction-related phenotypes that may influence treatment response (e.g., poor self-control, cognitive inflexibility, maladaptive decision-making), raising the possibility that they may represent novel therapeutic targets.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The neural basis of drug craving: An incentive-sensitization theory of addiction
Robinson, T. (1993) · Brain Research Reviews · doi:10.1016/0165-0173(93)90013-p · Cited by 7,346
Sokoloff, L., Reivich, M., Kennedy, C., Rosiers, M. H. D., Patlak, C. S., Pettigrew, K. D., Sakurada, O., & Shinohara, M. (1977) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1977.tb10649.x · Cited by 6,000
The physiology, signaling, and pharmacology of dopamine receptors
Beaulieu, J.-M., & Gainetdinov, R. R. (2011) · Pharmacological Reviews · doi:10.1124/pr.110.002642 · Cited by 2,763
Goldstein, R. Z., & Volkow, N. D. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.10.1642 · Cited by 2,667
Jentsch, J. D., & Taylor, J. R. (1999) · Psychopharmacology · doi:10.1007/pl00005483 · Cited by 1,545 · cited 2×
“…motivational and cognitive processes to produce optimal behavior (Jentsch and Taylor, 1999), frontostriatal impairments may contribute to deficits in executive functioning that have been observed in methamphetamine users (Dean et al., 2012; Jentsch and Taylor, 1999; Nordahl et al., 2003).”
BackgroundTraining induces changes in white-matter architecture
Scholz, J., Klein, M. C., Behrens, T. E. J., & Johansen-Berg, H. (2009) · Nature Neuroscience · doi:10.1038/nn.2412 · Cited by 1,508
Resting-state functional connectivity in neuropsychiatric disorders
Greicius, M. (2008) · Current Opinion in Neurology · doi:10.1097/wco.0b013e328306f2c5 · Cited by 1,180
Volkow, N. D., Chang, L., Wang, G.-J., Fowler, J. S., Ding, Y.-S., Sedler, M., Logan, J., Franceschi, D., Gatley, J., Hitzemann, R., et al. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.12.2015 · Cited by 916
McCann, U. D., Wong, D. F., Yokoi, F., Villemagne, V., Dannals, R. F., & Ricaurte, G. A. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-20-08417.1998 · Cited by 602 · cited 1×
“…generally lower in abstinent methamphetamine users than in matched non-users: deficits of 11-28% were measured using [11C]WIN-35,428 and [11C]d-threomethylphenidate (Johanson et al., 2006; McCann et al., 1998; McCann et al., 2008; Sekine et al., 2001; Volkow et al., 2001b; Volkow et al., 2001d).”
MethodDopaminergic Network Differences in Human Impulsivity
Buckholtz, J. W., Treadway, M. T., Cowan, R. L., Woodward, N. D., Li, R., Ansari, M. S., Baldwin, R. M., Schwartzman, A. N., Shelby, E. S., Smith, C. E., et al. (2010) · Science · doi:10.1126/science.1185778 · Cited by 600
Abnormal Brain Structure Implicated in Stimulant Drug Addiction
Ersche, K. D., Jones, P. S., Williams, G. B., Turton, A. J., Robbins, T. W., & Bullmore, E. T. (2012) · Science · doi:10.1126/science.1214463 · Cited by 546
Methamphetamine use: A comprehensive review of molecular, preclinical and clinical findings
Panenka, W. J., Procyshyn, R. M., Lecomte, T., MacEwan, G. W., Flynn, S. W., Honer, W. G., & Barr, A. M. (2013) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2012.11.016 · Cited by 432
Deficits in response inhibition associated with chronic methamphetamine abuse
Monterosso, J. R., Aron, A. R., Cordova, X., Xu, J., & London, E. D. (2005) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2005.02.002 · Cited by 425
Self-citationA multi‐site comparison of psychosocial approaches for the treatment of methamphetamine dependence
Rawson, R. A., Marinelli‐Casey, P., Anglin, M. D., Dickow, A., Frazier, Y., Gallagher, C., Galloway, G. P., Herrell, J., Huber, A., McCann, M. J., et al. (2004) · Addiction · doi:10.1111/j.1360-0443.2004.00707.x · Cited by 387
Methamphetamine causes microglial activation in the brains of human abusers
Sekine, Y., Ouchi, Y., Sugihara, G., Takei, N., Yoshikawa, E., Nakamura, K., Iwata, Y., Tsuchiya, K. J., Suda, S., Suzuki, K., et al. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.1179-08.2008 · Cited by 381
Lee, B., London, E. D., Poldrack, R. A., Farahi, J., Nacca, A., Monterosso, J. R., Mumford, J. A., Bokarius, A. V., Dahlbom, M., Mukherjee, J., et al. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.3765-09.2009 · Cited by 374
Self-citationAron, A. R., Monsell, S., Sahakian, B. J., & Robbins, T. W. (2004) · Brain · doi:10.1093/brain/awh169 · Cited by 372
Paulus, M. P., Tapert, S. F., & Schuckit, M. A. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.7.761 · Cited by 369
Structural Brain Alterations following 5 Days of Intervention: Dynamic Aspects of Neuroplasticity
May, A., Hajak, G., Gänßbauer, S., Steffens, T., Langguth, B., Kleinjung, T., & Eichhammer, P. (2007) · Cerebral Cortex · doi:10.1093/cercor/bhj138 · Cited by 344
Monterosso, J. R., Ainslie, G., Xu, J., Cordova, X., Domier, C. P., & London, E. D. (2007) · Human Brain Mapping · doi:10.1002/hbm.20281 · Cited by 335 · cited 4×
“Methamphetamine users exhibit steeper temporal discounting than healthy controls (Monterosso et al., 2007; Schwartz et al., 2010); and this characteristic has been associated with lower gray-matter density in the superior frontal gyrus but greater graymatter density in putamen, ventral striatum and…”
BackgroundSelf-citationReward Signals, Attempted Suicide, and Impulsivity in Late-Life Depression
Dombrovski, A. Y., Szanto, K., Clark, L., Reynolds, C. F., & Siegle, G. J. (2013) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.75 · Cited by 289
Brecht, M.-L., & Herbeck, D. (2014) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2014.02.702 · Cited by 280 · cited 2×
“While many users seek treatment for methamphetamine abuse, which accounts for well over 100,000 admissions to drug treatment facilities annually in the U.S. alone (SAMHSA, 2014b), the vast majority relapse (Brecht and Herbeck, 2014; McKetin et al., 2012).”
BackgroundDifferent Forms of Self-Control Share a Neurocognitive Substrate
Tabibnia, G., Monterosso, J. R., Baicy, K., Aron, A. R., Poldrack, R. A., Chakrapani, S., Lee, B., & London, E. D. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.2859-10.2011 · Cited by 271
Self-citationFisher, B. E., Li, Q., Nacca, A., Salem, G. J., Song, J., Yip, J., Hui, J. S., Jakowec, M. W., & Petzinger, G. M. (2013) · Neuroreport · doi:10.1097/wnr.0b013e328361dc13 · Cited by 247
Rawson, R. A., McCann, M. J., Flammino, F., Shoptaw, S., Miotto, K., Reiber, C., & Ling, W. (2006) · Addiction · doi:10.1111/j.1360-0443.2006.01312.x · Cited by 238
Cognitive function and nigrostriatal markers in abstinent methamphetamine abusers
Johanson, C.-E., Frey, K. A., Lundahl, L. H., Keenan, P., Lockhart, N., Roll, J., Galloway, G. P., Koeppe, R. A., Kilbourn, M. R., Robbins, T., et al. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0330-6 · Cited by 233
Ghahremani, D. G., Lee, B., Robertson, C. L., Tabibnia, G., Morgan, A. T., De Shetler, N., Brown, A. K., Monterosso, J. R., Aron, A. R., Mandelkern, M. A., et al. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.4284-11.2012 · Cited by 227 · cited 1×
“Given relationships between striatal D2-type receptor availability and decision-making (Kohno et al., 2013), inhibitory control (Ghahremani et al., 2012) and trait impulsivity (Buckholtz et al., 2010) in healthy controls, an upregulation of D2 receptors may provide clinical improvements in…”
BackgroundSelf-citationCortical activation during delay discounting in abstinent methamphetamine dependent individuals
Hoffman, W. F., Schwartz, D. L., Huckans, M. S., McFarland, B. H., Meiri, G., Stevens, A. A., & Mitchell, S. H. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1261-1 · Cited by 210
McKetin, R., Najman, J. M., Baker, A. L., Lubman, D. I., Dawe, S., Ali, R., Lee, N. K., Mattick, R. P., & Mamun, A. (2012) · Addiction · doi:10.1111/j.1360-0443.2012.03933.x · Cited by 147
Smout, M. F., Longo, M., Harrison, S., Minniti, R., Wickes, W., & White, J. M. (2010) · Substance Abuse · doi:10.1080/08897071003641578 · Cited by 129
Simon, S. L., Dean, A. C., Cordova, X., Monterosso, J. R., & London, E. D. (2010) · Journal of Studies on Alcohol and Drugs · doi:10.15288/jsad.2010.71.335 · Cited by 117
Drug abstinence and cognitive control in methamphetamine-dependent individuals
Salo, R., Nordahl, T. E., Galloway, G. P., Moore, C. D., Waters, C., & Leamon, M. H. (2009) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2009.03.004 · Cited by 109
Chou, Y.-H., Huang, W.-S., Su, T.-P., Lu, R.-B., Wan, F.-J., & Fu, Y.-K. (2007) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2006.05.002 · Cited by 78
O'connell, R. G., Bellgrove, M. A., Dockree, P. M., & Robertson, I. H. (2006) · Neuropsychological Rehabilitation · doi:10.1080/09602010500200250 · Cited by 74
Stewart, J. L., Connolly, C. G., May, A. C., Tapert, S. F., Wittmann, M., & Paulus, M. P. (2014) · Addiction · doi:10.1111/add.12403 · Cited by 68
Miles, S. W., Sheridan, J., Russell, B., Kydd, R., Wheeler, A., Walters, C., Gamble, G., Hardley, P., Jensen, M., Kuoppasalmi, K., et al. (2013) · Addiction · doi:10.1111/add.12109 · Cited by 63
Cited by
Neurobiology, Clinical Presentation, and Treatment of Methamphetamine Use Disorder: A Review
Paulus, M. P., & Stewart, J. L. (2020) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2020.0246 · Cited by 310
Tardelli, V. S., Bisaga, A., Arcadepani, F. B., Gerra, G., Levin, F. R., & Fidalgo, T. M. (2020) · Psychopharmacology · doi:10.1007/s00213-020-05563-3 · Cited by 151
Brooks, S. J., Burch, K. H., Maiorana, S. A., Cocolas, E., Schioth, H. B., Nilsson, E. K., Kamaloodien, K., & Stein, D. J. (2016) · NeuroImage: Clinical · doi:10.1016/j.nicl.2016.08.019 · Cited by 50
“(Morales et al., 2012; London et al., 2014), which could be associated with microglial and other neural processes involved in rapid reorganisation prior to neurogenesis (Nixon et al.”
Influential
Metadata
- Authors
- London, E. D., Kohno, M., Morales, A. M., & Ballard, M. E.
- Venue
- Brain Research
- Publisher
- Elsevier BV
- Published
- 2015-12
- Volume
- 1628
- Issue
- Pt A
- Pages
- 174-185
- ISSN
- 0006-8993 (ISSN-L)
- OpenAlex
- W1989816896
- Cited by
- 184
- References
- 36
- FWCI
- 5.37
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.